Angiography Devices Market Size by Product, Technology, Procedure, Application, End User, Region – Revenue Pool Analysis, Margin Structure Assessment, Capital Flow Trends, Competitive Benchmarking & Forecast to 2034
Overview
Global Angiography Devices Market size was valued at USD 15.9 Bn in 2025 and the total Global Angiography Devices Market revenue is expected to grow by 6% from 2026 to 2034, reaching nearly USD 26.86 Bn by 2034.
Angiography Devices Market Overview:
Angiography devices are medical imaging systems that are used to visualize blood vessels and blood flow, mainly to diagnose and treat vascular conditions such as blockage, aneurysm and deformities. They include X-ray based systems (such as DSA), catheters, contrast injectors and advanced software for real time image guidance. The expansion of the global angiography devices market is due to increasing prevalence of cardiovascular disorders, growing demand for minimal invasive processes and technological progress in the imaging system, such as AI in operated image analysis, 3D angiography, and low dose radiation system.
North America led Global Angiography device market in 2025, which is powered by advanced healthcare infrastructure, high adoption of innovative technologies and strong reimbursement policies, while Asia shows rapid growth due to growth in Health Services, growing access to government investments and modern imaging equipment. Key players like Siemens Healthineers, GE Healthcare, Philips, Medtronic, and Canon Medical Systems dominate angiography devices market growth with innovations in digital subtraction angiography (DSA), hybrid operating rooms, and catheter-based interventions. These companies are also integrating AI operated diagnostic, sustainable manufacturing practice and teleradiology solution to increase efficiency and regulatory compliance. Primary end users include hospitals, special clinics and clinical centres, which improves the patient's access to growing adoption in ambulatory surgical centres and vascular imaging in emerging telemedicine platforms.
Angiography Devices Market Size, Share and Growth Analysis
To know about the Research Methodology :- Request Free Sample Report
Angiography Devices Market Dynamics:
Bolstering Demand for Interventional Angiography Systems in Minimally Invasive Surgeries to Boost Angiography Devices Market
Minimally invasive surgeries are less expensive and faster than traditional surgeries. These surgical procedures improve patient safety, reduce scarring, ensure faster recovery, and shorten hospital stays. According to a news article published in JAMA (Journal of the American Medical Association), research conducted by investigators at Johns Hopkins Medicine, a division of Johns Hopkins University (US), revealed that performing MIS procedures instead of traditional surgeries could save American hospitals between USD 281 million and USD 341 million per year.
Angiography is preferred in minimally invasive procedures because angiograms generated during the diagnosis phase present a detailed, clear, and accurate picture of a patient's blood vessels in the heart, eliminating the need for costly invasive surgeries. As a result of this, medical professionals are increasingly choosing minimally invasive surgical procedures over traditional open procedures due to the clinical and cost advantages provided by the former. This, in turn, is boosting the growth of the angiography devices market.
Growing Demand from Doctors and Healthcare Workers to Drive Angiography Devices Market
The market's key growth drivers are expected to be growing application scope and technological innovations. Other prominent factors driving angiography devices market growth include investments in the healthcare sector, an increasing geriatric population, and the rising prevalence of cardiovascular diseases (CVDs). According to the World Health Organization (WHO), in 2025, low-income and middle-income countries accounted for more than 78% of CVD deaths due to a lack of easy access to primary healthcare programs for early detection and treatment. Cardiovascular disease is the leading cause of death in the United States. According to the American Heart Association statistical fact sheet 2021, CVD was responsible for 46.8% of all deaths, followed by stroke (17.8%), high blood pressure (10.4%), and heart failure (9.5%). By 2035, more than 132 million adults in the country are expected to have one or more forms of CVD.
According to the WHO, factors such as tobacco and alcohol use, poor diet, obesity, and physical inactivity all increase the risk of CVD. Obesity in adults increased from 35.9% to 38.7% in 2025, and in children from 17.9% to 18.2%. The country spent approximately USD 10,448 per person on healthcare. The changing regulatory environment is likely to have an impact on American manufacturers. These all aspects are boosting the angiography devices market and are expected to do so during the forecast period.
Lack of Skilled Professionals to Restrain Angiography Devices Market
Angioplasty is a safe procedure when performed by a trained professional. According to the MMR, the angiography devices market is being hampered by a lack of skilled professionals in the healthcare industry in comparison with the growing number of patients. Additionally, Because of age-related changes in the body, the procedure becomes technically difficult for patients over the age of 75.
Increasing Investment in Research and Development to Create Opportunities in Angiography Devices Market
Increased investment in R&D activity by medical technology companies as a result of the rising prevalence of chronic disease, as well as an easy approval process for those devices by regulatory authorities, are expected to boost the angiography devices market growth in the forecast years. The US Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH) approved or authorized 13 devices in 2021, according to an article published by Regulatory Affairs Professionals Society (RAPS). Additionally, growing R&D spending by pharmaceutical, biopharmaceutical, and medical device companies is supplementing the growth of the angiography devices market during the forecast period.
Emerging Economies to Boost Opportunities in Angiography Devices Market
Emerging markets like China, Brazil, Mexico, and India offer significant opportunities. Participants in the angiography devices market medical devices are in high demand in these countries populations are growing as a result of rapid growth in medical tourism, as well as the growing population, and rising disposable incomes. These countries also have a large and well-educated labour force. They have powerful Potential for growth and higher-than-average returns on investment Moreover these countries have lax import/export policies and are underserved in most areas which could help businesses with brand development Subsidies and expenses incurred by the government, as well as taxation Relaxations in these countries may also aid business growth.
Angiography Devices Market Segment Analysis:
Based on Product, the global angiography devices market is divided into accessories, systems, guidewires, catheters, balloons, vascular closure devices, and contrast media. Because of ongoing investments, technological advancements, and a growing scope of applications, the angiography systems segment led the market in 2025. These systems have progressed from catheter-based minimally invasive procedures to digitalized procedures.
Contrast media is expected to be the fastest-growing product segment during the forecast years. These products are widely used to improve the visibility of blood vessels in imaging techniques such as CT angiography, MRA, and X-ray. It is also used in projectional radiography and fluoroscopy. Iodine, barium-sulphate, and gadolinium are some of the radiocontrast agents that are used.
Based on the Technology, the global angiography devices market is divided into three categories based on technology: X-ray, MRA, and CT. Companies are investing heavily in the development of new technologies, which will bolster angiography devices market growth. The market is also expected to be driven by the need to reduce radiation dose, improve image quality, and emerging cath lab trends.
MRA is expected to be the fastest-growing technology in the diagnosis of heart disease due to its low radiation exposure. MRA can acquire images in any anatomical plane with excellent soft tissue contrast in 3D. The introduction of 3.0T MR imaging has greatly improved the diagnosis of coronary artery disease. These factors are said to boost segment growth as well.
Based on the Procedure, the global angiography devices market is divided into three categories based on the procedure: coronary, endovascular, and neurovascular. In 2025, the coronary angiography segment dominated the angiography devices market. The rising prevalence of coronary artery disease (CAD) and the availability of less invasive imaging modalities are driving up demand for coronary angiography in developing countries like China and India.
Constant advancements in imaging technology have allowed for more accurate disease diagnosis. The imaging skill has evolved from single-slice CT to multislice CT, which provides excellent CAD visualization and assessment. Coronary CT angiography, cardiac Magnetic Resonance Imaging (MRI), cardiac Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and integrated SPECT/CT and PET/CT are all available for diagnosis.
Based on the Application, the global angiography devices market is expected to be driven by rising awareness of CVDs and associated risk factors. CAD is the leading cause of death and disability worldwide. The joint initiatives of the WHO and state governments to raise awareness about heart diseases and their underlying causes are also expected to contribute to the growth of the angiography equipment market.
In 2025, diagnostic applications dominated the market. CTA and MRA advancements provide useful information not only in cardiology but also in neurology, such as cerebral aneurysms, acute stroke, brain arteriovenous malformation, dural arteriovenous fistula, suspected cerebral vasculitis, and occlusive diseases.
Based on the End User, the Hospital Segment dominated the angiography devices market in 2025 and is expected to continue during the forecast period. The availability of a larger patient pool, high resource availability, high penetration in diverse geographical locations, availability of accompanying healthcare infrastructure and procedures, availability of skilled labour, and affordability through government funding are the main factors contributing to the hospital segment's dominance. The number of complex cardiac disease cases is increasing, as is the number of deaths from cardiovascular diseases in both developed and emerging markets.
Hospitals attract a large patient population suffering from cardiovascular diseases due to their greater accessibility and affordability when compared to specialty clinics. Hospitals' profitability index rises as a result of bulk purchase discounts and trade agreements with manufacturers and suppliers. Furthermore, these trade agreements open new avenues for manufacturers to timely upgrade and gain early access to technologically advanced products, enhancing the hospital's treatment capability.
Angiography Devices Market Recent Development
| Date | Company | Development | Impact |
|---|---|---|---|
| 15 January 2025 | Siemens Healthineers | Siemens Healthineers launched its next-generation ARTIS icono biplane system featuring advanced AI-driven dose reduction software for complex neuro-angiography procedures. | The system enhances visualization accuracy while reducing radiation exposure by 30% for patients and clinical staff during lengthy interventional procedures. |
| 18 April 2025 | Koninklijke Philips N.V. | Philips received FDA 510(k) clearance for its integrated Azurion 7 C20 image-guided therapy platform tailored for structural heart and peripheral vascular angiography. | This clearance expands access to 3D roadmap navigation, significantly improving procedural efficiency and hospital workflow throughput. |
| 12 August 2025 | Canon Medical Systems | Canon Medical Systems acquired a strategic stake in a specialized catheter developer to co-develop high-resolution intravascular ultrasound (IVUS) angiography catheters. | The partnership boosts Canon's portfolio in hybrid interventional suites, expanding its competitive footprint in high-growth Asian markets. |
| 04 November 2025 | GE HealthCare | GE HealthCare announced the commercial availability of its Allia IGS 7 angiography suite embedded with real-time OmniLegend digital mapping capabilities. | The innovation accelerates coronary arterial mapping and reduces contrast media usage by up to 20% in high-risk cardiology cases. |
| 20 February 2026 | Shimadzu Corporation | Shimadzu Corporation opened a new $45 million manufacturing and R&D facility dedicated to flat-panel detector angiography systems. | The expansion increases regional production scale by 40% to meet accelerating global demand for minimally invasive cardiovascular tools. |
Angiography Devices Market Regional Insights:
North America dominated the Angiography Devices Market in 2025
North America is expected to dominate the angiography devices market due to the high adoption rate of minimally invasive procedures, reimbursement availability, rising geriatric population, and high medical equipment replacement rates. Factors such as a strong network of medical device companies and a large number of hospitals spread across cities and states with good funding opportunities primarily help the region dominate the market.
Moreover, good support from government facilities aids in the development required for the overall treatment of cardiovascular diseases in the region's healthcare sector. After North America, Europe is the second-largest market. The high prevalence of cardiovascular diseases, high government investments, faster product approval procedures, and rising adoption of angiography devices due to a large number of angiography screening procedures performed all contribute to Europe's significant share.
Angiography Devices Market Competitive Landscape:
Key Players in the Angiography Devices Market are Siemens Healthineers AG, GE Healthcare, Philips Healthcare, Canon Medical Systems, Medtronic, Shimadzu Corporation, and Boston Scientific lead the market with advanced imaging systems and minimally invasive solutions. Siemens Healthineers have 25% market share in the premium angiography system, powered by its Artis pheno and Q.zen platforms, which reduce the radiation dose by 50% by increasing the imaging accuracy by 50%. Siemens dominates 40% hybrid or installation globally and has obtained FDA/CE approval for 5 AI-operated angiography tools in 2025 including Syngo Dynact. Competitors such as Philips (Azurian) and GE (IGS7) trails in AI integration are occupying the sale of 60% new AI-operated angiography in Siemens Europe and North America. Strategic participation with Mayo Clinic and Johns Hopkins further strengthens its clinical verification and R&D pipeline.
Angiography Devices Market Key Trends:
• AI-Powered Precision-Advanced AI integration (e.g., real-time lesion detection, automated vessel tracking) reduces procedural time by 20–30% and enhances diagnostic accuracy, with 50% of new systems adopting embedded AI tools.
• Shift to Hybrid Ors-Rising demand for hybrid operating rooms (growing at 12% CAGR) combines angiography with robotic surgery, driven by minimally invasive cardiac and neurovascular interventions.
• Sustainability-Driven Innovations-Manufacturers (e.g., Siemens, Philips) focus on low-dose radiation systems (cutting exposure by 40%) and recyclable catheter materials to meet stricter EU/US environmental regulations.
Angiography Devices Market Key Developments:
1. GE Healthcare (US)-March 2025: Launched the Allia IGS 8, a next-gen angiography system with AI-driven real-time 3D vessel mapping, reducing procedure time by 25%.
2. Boston Scientific Corporation (US)-February 2025: Received FDA approval for the Ranger Drug-Coated Balloon, expanding peripheral angiography treatment options for arterial disease.
3. Siemens Healthineers AG (Germany)-January 2025: Introduced syngo Angio Insight, an AI-powered analytics tool for automated stenosis detection, integrated into Artis Q.zen systems.
4. Shimadzu Corporation (Japan)-November 2024: Unveiled the Trinias™ Mobile Angio System, a compact, high-resolution mobile C-arm for hybrid ORs and emergency interventions.
5. Canon Medical Systems (Japan)-April 2024: Launched the Alphenix™ 4D CT Angio System, combining real-time 4D imaging with ultra-low radiation dose technology, enhancing precision in complex vascular interventions.
Angiography Devices Market Scope: Inquiry Before Buying
| Angiography Devices Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | US $ 15.9 Bn. |
| Forecast Period 2026 to 2034 CAGR: | 6% | Market Size in 2034: | US $ 26.86 Bn. |
| Segments Covered: | by Product | Angiography systems Catheters Guidewire Balloons Contrast media Vascular closure devices Angiography accessories |
|
| by Technology | X-ray MRA CT |
||
| by Procedure | Coronary Endovascular Neurovascular |
||
| by Application | Diagnostic Therapeutic |
||
| by End User | Hospitals Diagnostic Centers Ambulatory Surgical Centers |
||
Angiography Devices Market, by region
North America (United States, Canada and Mexico)
Europe (United Kingdom, France, Germany, Italy, Spain, Sweden, Russia, Rest of Europe)
Asia Pacific (China, Japan, South Korea, India, Australia, Malaysia, Thailand, Vietnam, Indonesia, Philippines, Rest of APAC)
Middle East and Africa (South Africa, GCC, Nigeria, Egypt, Turkey, Rest of MEA)
South America (Brazil, Argentina, Colombia, Chile, Peru, Rest of South America)
Angiography Devices Market Key Players are:
North America
1. Abbott Laboratories (US)
2. GE Healthcare (US)
3. Cordis Corporation (US)
4. AngioDynamics (US)
5. Boston Scientific Corporation (US)
6. GENERAL ELECTRIC COMPANY (US)
7. Merit Medical Systems (US)
Europe
8. Siemens Healthineers AG (Germany)
9. B. Braun Melsungen AG (Germany)
10. Royal Philips Electronics (Netherlands)
11. Koninklijke Philips N.V. (Netherlands)
Asia Pacific
12. Canon Inc. (Japan)
13. Terumo Corporation (Japan)
14. Shimadzu Corporation (Japan)
15. Toshiba Medical Systems Corporation (Japan)
16. MEDI TECH DEVICES PVT LTD (India)
17. ST. STONE MEDICAL DEVICES PVT. LTD. (India)
18. InterMed Medical (India)
Frequently Asked Questions:
1] What equipment is used for angiography?
Ans. A radiographic table, one or two x-ray tubes, and a video monitor are typically used in this exam. Fluoroscopy is the process of converting x-rays into video images. It is used by doctors to monitor and guide procedures. The video is created by an x-ray machine and a detector suspended above the exam table.
2] What is the principle of angiography?
Ans. Angiography is a technique that is used to image anatomical and structural details of the vascular system by detecting contrast injected into a blood vessel and projecting this on a series of x-rays to outline the inner vessel wall and show flow through the lumen.
3] Which angiography is best for the heart?
Ans. Recent advancements in multi-detector computed tomography angiography (CTA) have enabled rapid, non-invasive coronary artery imaging in patients suspected of having CHD. When compared to cardiac catheterization, CTA has a higher sensitivity for identifying patients with CHD.
4] Which is the dominant region in the Angiography Devices Market?
Ans. North America dominated the Angiography Devices Market in 2025 and is expected to dominate during forecast period.